Anti-angiogenic effect of exo-LncRNA TUG1 in myocardial infarction and modulation by remote ischemic conditioning

Dang, Yini; Hua, Wenjie; Zhang, Xintong; Sun, Hao; Zhang, Yingjie; Yu, Binbin; Wang, Shengrui; Zhang, Min; Kong, Zihao; Pan, Dijia; Chen, Ying; Li, Shurui; Liu, Yuan; Reinhardt, Jan D.; Lü, Xiao; Zheng, Yu

doi:10.1007/s00395-022-00975-y

Cited by 7 publications

(2 citation statements)

References 74 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although TUG1 has 20 transcripts, 19 of them do not have the ability to encode proteins ( Farzaneh et al, 2022 ). Previous studies have shown that TUG1 played an oncogenic role in tumors such as colorectal ( Ibrahim et al, 2023 ), prostate ( Yu et al, 2019 ), bladder ( Tan et al, 2022 ), lung ( Li et al, 2021a ), oral squamous cell ( Jiang et al, 2022 ), and ovarian cancers ( Zhan et al, 2020 ), as well as being involved in the pathogenesis of non-cancerous diseases such as renal ischemia-reperfusion injury ( Sun et al, 2022b ), pulmonary fibrosis ( Qi et al, 2023 ), and myocardial infarction ( Dang et al, 2023 ). Thus, TUG1 could act as a pathogenic factor in a tissue-specific or environment-specific manner.…”

Section: Discussionmentioning

confidence: 99%

The role of competing endogenous RNA network in the development of hepatocellular carcinoma: potential therapeutic targets

Tang,

Li,

Zheng

et al. 2024

Front. Cell Dev. Biol.

View full text Add to dashboard Cite

The current situation of hepatocellular carcinoma (HCC) management is challenging due to its high incidence, mortality, recurrence and metastasis. Recent advances in gene genetic and expression regulation have unveiled the significant role of non-coding RNA (ncRNA) in various cancers. This led to the formulation of the competing endogenous RNA (ceRNA) hypothesis, which posits that both coding RNA and ncRNA, containing miRNA response elements (MRE), can share the same miRNA sequence. This results in a competitive network between ncRNAs, such as lncRNA and mRNA, allowing them to regulate each other. Extensive research has highlighted the crucial role of the ceRNA network in HCC development, impacting various cellular processes including proliferation, metastasis, cell death, angiogenesis, tumor microenvironment, organismal immunity, and chemotherapy resistance. Additionally, the ceRNA network, mediated by lncRNA or circRNA, offers potential in early diagnosis and prevention of HCC. Consequently, ceRNAs are emerging as therapeutic targets for HCC. The complexity of these gene networks aligns with the multi-target approach of traditional Chinese medicine (TCM), presenting a novel perspective for TCM in combating HCC. Research is beginning to show that TCM compounds and prescriptions can affect HCC progression through the ceRNA network, inhibiting proliferation and metastasis, and inducing apoptosis. Currently, the lncRNAs TUG1, NEAT1, and CCAT1, along with their associated ceRNA networks, are among the most promising ncRNAs for HCC research. However, this field is still in its infancy, necessitating advanced technology and extensive basic research to fully understand the ceRNA network mechanisms of TCM in HCC treatment.

show abstract

Section: Discussionmentioning

confidence: 99%

The role of competing endogenous RNA network in the development of hepatocellular carcinoma: potential therapeutic targets

Tang,

Li,

Zheng

et al. 2024

Front. Cell Dev. Biol.

View full text Add to dashboard Cite

show abstract

“… 169 Experiments in rats have shown that EVs containing LncRNA TUG1 can be potential therapeutic targets for myocardial infarction. 170 In terms of assessing endometrial receptivity, biopsies of EVs originating from the endometrium can avoid endometrial injury associated with traditional biopsy methods. 171 Brain-derived EVs released by the central nervous system have been considered as diagnostic and prognostic biomarkers for Alzheimer’s disease.…”

Section: Evs In Combination With Other Treatmentsmentioning

confidence: 99%